GSK malaria vaccine could save millions of lives

The following report published in The Guardian today provides encouraging global health news -- GSK's new vaccine against malaria has been shown to halve the risk of malaria.

Malaria vaccine could save millions of children's lives

Millions of small children's lives could be saved by a new vaccine that has been shown to halve the risk of malaria in the first large-scale trials across seven African countries.

Global pharmaceutical industry contributes action plan and research to fighting NCDs in the developing world

Coinciding with the UN High-Level meeting on non-communicable diseases, the International Federation of Pharmaceutical Manufacturers released the following statement outlining steps they're taking to address the growing global challenge of NCDs.

The fight against TB: Bayer donates drugs to WHO program

According to a report from PharmaTimes, Bayer will donate 620,000 tablets of its antibiotic moxifloxacin in order to help tackle multi-drug resistant tuberculosis.

The drugs will be provided to the World Health Organization for use in its Stop Tuberculosis Partnership, with the WHO expected to provide the antibiotics to China's national tuberculosis programme.

UN protects millions of children in DR Congo with anti-measles vaccination

Some 3.1 million children in the Democratic Republic of the Congo (DRC) have been vaccinated against measles in a United Nations-coordinated campaign to combat the disease outbreak which has claimed the lives of 1,145 children since the start of this year.

The measles epidemic affected a total of 115,600 children between January and June, the UN Office for the Coordination of Humanitarian Affairs (OCHA) said in a press release issued yesterday, adding that the vaccination campaign was funded with $1.9 million.

Dengue - new site highlights disease information and research

Population growth, urbanization and rapid mass transportation have resulted in an explosive increase in dengue cases – from 1.2 million in 1998 to as many as 500 million annual cases today – and contributed to an ever growing number of countries and people at risk of infection. Dengue is now endemic in over 100 countries across the globe, and is the most prevalent mosquito-borne viral disease.

IFPMA launches NCD Framework for Action

IFPMA (International Federation of Pharmaceutical Manufacturers & Associations) recently released a NCD Framework for Action, highlighting specific areas of action including:  innovation, access and affordability, prevention and health education.  The document underscores the essential role of partnerships in addressing the challenge of non-communicable disease.

Read more about the NCD Framework for Action:

Global Health Initiative: progress and future plans

The following is an interesting interview by PBS News Hour with the Executive Director of the U.S. Global Health Initiative.

Q&A: Head of the Global Health Initiative Talks Next Moves

BY TALEA MILLER

First announced in 2009, the initiative was envisioned as a comprehensive approach to health in the developing world that would integrate HIV/AIDS and other health services, and strengthen health systems.

Pages

Subscribe to Patients and Patents RSS